Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey


Por: Fine, SW, Trpkov, K, Amin, MB, Algaba, F, Aron, M, Baydar, DE, Beltran, AL, Brimo, F, Cheville, JC, Colecchia, M, Comperat, E, Costello, T, da Cunha, IW, Delprado, W, DeMarzo, AM, Giannico, GA, Gordetsky, JB, Guo, CC, Hansel, DE, Hirsch, MS, Huang, JT, Humphrey, PA, Jimenez, RE, Khani, F, Kong, MX, Kryvenko, ON, Kunju, LP, Lal, P, Latour, M, Lotan, T, Maclean, F, Magi-Galluzzi, C, Mehra, R, Menon, S, Miyamoto, H, Montironi, R, Netto, GJ, Nguyen, JK, Osunkoya, AO, Parwani, A, Pavlovich, CP, Robinson, BD, Rubin, MA, Shah, RB, So, JS, Takahashi, H, Tavora, F, Tretiakova, MS, True, L, Wobker, SE, Yang, XMJ, Zhou, M, Zynger, DL, Epstein, JI

Publicada: 1 may 2021 Ahead of Print: 1 may 2021
Resumen:
Purpose: To survey urologic clinicians regarding interpretation of and practice patterns in relation to emerging aspects of prostate cancer grading, including quantification of high-grade disease, cribriform/intraductal carcinoma, and impact of magnetic resonance imaging-targeted needle biopsy. Materials and methods: The Genitourinary Pathology Society distributed a survey to urology and urologic oncology-focused societies and hospital departments. Eight hundred and thirty four responses were collected and analyzed using descriptive statistics. Results: Eighty percent of survey participants use quantity of Gleason pattern 4 on needle biopsy for clinical decisions, less frequently with higher Grade Groups. Fifty percent interpret "tertiary" grade as a minor/< 5% component. Seventy percent of respondents would prefer per core grading as well as a global/overall score per set of biopsies, but 70% would consider highest Gleason score in any single core as the grade for management. Seventy five percent utilize Grade Group terminology in patient discussions. For 45%, cribriform pattern would affect management, while for 70% the presence of intraductal carcinoma would preclude active surveillance. Conclusion: This survey of practice patterns in relationship to prostate cancer grading highlights similarities and differences between contemporary pathology reporting and its clinical application. As utilization of Gleason pattern 4 quantification, minor tertiary pattern, cribriform/intraductal carcinoma, and the incorporation of magnetic resonance imaging-based strategies evolve, these findings may serve as a basis for more nuanced communication and guide research efforts involving pathologists and clinicians. (C) 2020 Elsevier Inc. All rights reserved.

Filiaciones:
Fine, SW:
 Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA

Trpkov, K:
 Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada

 Alberta Precis Labs, Calgary, AB, Canada

Amin, MB:
 Univ Tennessee Hlth Sci, Dept Pathol & Lab Med & Urol, Memphis, TN USA

Algaba, F:
 Fundacio Puigvert, Dept Pathol, Barcelona, Spain

Aron, M:
 Univ Southern Calif, Dept Pathol, Los Angeles, CA 90007 USA

Baydar, DE:
 Koc Univ, Fac Med, Dept Pathol, Istanbul, Turkey

Beltran, AL:
 Champalimaud Ctr Unknown, Dept Pathol, Lisbon, Portugal

Brimo, F:
 McGill Univ Hlth Ctr, Dept Pathol, Montreal, PQ, Canada

Cheville, JC:
 Mayo Clin, Dept Pathol, Rochester, MN USA

Colecchia, M:
 Fdn IRCCS Ist Nazl Tumori, Dept Pathol & Lab Med, Milan, Italy

Comperat, E:
 Sorbonne Univ, Dept Pathol, Hop Tenon, Paris, France

Costello, T:
 Royal Melbourne Hosp, Dept Urol, Melbourne, Vic, Australia

da Cunha, IW:
 Rede DOR Sao Luiz Sao Paulo, Pathol Dept, Sao Paulo, SP, Brazil

Delprado, W:
 Douglass Hanly Moir Pathol, Sydney, NSW, Australia

DeMarzo, AM:
 Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA

Giannico, GA:
 Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA

Gordetsky, JB:
 Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA

Guo, CC:
 Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA

Hansel, DE:
 Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA

Hirsch, MS:
 Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA

Huang, JT:
 Duke Univ, Sch Med, Dept Pathol, Durham, NC 27706 USA

Humphrey, PA:
 Yale Sch Med, Dept Pathol, New Haven, CT USA

Jimenez, RE:
 Mayo Clin, Dept Pathol, Rochester, MN USA

Khani, F:
 Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA

 Weill Cornell Med, Dept Urol, New York, NY USA

Kong, MX:
 Kaiser Permanente Sacramento Med Ctr, Dept Pathol, Sacramento, CA USA

Kryvenko, ON:
 Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA

 Univ Miami, Miller Sch Med, Dept Lab Med, Miami, FL 33136 USA

 Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA

Kunju, LP:
 Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA

Lal, P:
 Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA

Latour, M:
 Univ Montreal, Dept Pathol, CHUM, Montreal, PQ, Canada

Lotan, T:
 Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA

Maclean, F:
 Douglass Hanly Moir Pathol, Sydney, NSW, Australia

Magi-Galluzzi, C:
 Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA

Mehra, R:
 Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA

Menon, S:
 Tata Mem Hosp, Dept Surg Pathol, Mumbai, Maharashtra, India

Miyamoto, H:
 Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA

 Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA

Montironi, R:
 Polytech Univ Marche Reg, United Hosp, Sch Med, Sect Pathol Anat, Ancona, Italy

Netto, GJ:
 Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA

Nguyen, JK:
 Cleveland Clin, Robert J Tomsich Pathol & Lab Med Inst, Cleveland, OH 44106 USA

Osunkoya, AO:
 Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA

Parwani, A:
 Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA

Pavlovich, CP:
 Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21205 USA

 Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA

Robinson, BD:
 Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA

 Weill Cornell Med, Dept Urol, New York, NY USA

Rubin, MA:
 Univ Bern, Dept BioMed Res, Bern, Switzerland

Shah, RB:
 Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX USA

So, JS:
 St Lukes Med Ctr, Inst Pathol, Quezon City, Philippines

 St Lukes Med Ctr, Inst Pathol, Global City, Philippines

Takahashi, H:
 Jikei Univ, Dept Pathol, Sch Med, Tokyo, Japan

Tavora, F:
 Univ Fed Ceara, Argos Lab, Fortaleza, Ceara, Brazil

Tretiakova, MS:
 Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA

True, L:
 Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA

Wobker, SE:
 Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA

 Univ N Carolina, Dept Urol, Chapel Hill, NC USA

Yang, XMJ:
 Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA

Zhou, M:
 Tufts Med Ctr, Dept Pathol, Boston, MA 02111 USA

Zynger, DL:
 Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA

Epstein, JI:
 Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA

 Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21205 USA

 Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA
ISSN: 10781439
Editorial
ELSEVIER SCIENCE INC, STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 39 Número: 5
Páginas:
WOS Id: 000653487300010
ID de PubMed: 32948433
imagen Open Access

MÉTRICAS